189 related articles for article (PubMed ID: 11368792)
21. Heme oxygenase isoforms differ in their subcellular trafficking during hypoxia and are differentially modulated by cytochrome P450 reductase.
Linnenbaum M; Busker M; Kraehling JR; Behrends S
PLoS One; 2012; 7(4):e35483. PubMed ID: 22545110
[TBL] [Abstract][Full Text] [Related]
22. Diversity in mechanisms of substrate oxidation by cytochrome P450 2D6. Lack of an allosteric role of NADPH-cytochrome P450 reductase in catalytic regioselectivity.
Hanna IH; Krauser JA; Cai H; Kim MS; Guengerich FP
J Biol Chem; 2001 Oct; 276(43):39553-61. PubMed ID: 11509577
[TBL] [Abstract][Full Text] [Related]
23. A model for human cytochrome P450 2D6 based on homology modeling and NMR studies of substrate binding.
Modi S; Paine MJ; Sutcliffe MJ; Lian LY; Primrose WU; Wolf CR; Roberts GC
Biochemistry; 1996 Apr; 35(14):4540-50. PubMed ID: 8605204
[TBL] [Abstract][Full Text] [Related]
24. CYP2D6 catalyzes tamoxifen 4-hydroxylation in human liver.
Dehal SS; Kupfer D
Cancer Res; 1997 Aug; 57(16):3402-6. PubMed ID: 9270005
[TBL] [Abstract][Full Text] [Related]
25. Expression and characterization of truncated human heme oxygenase (hHO-1) and a fusion protein of hHO-1 with human cytochrome P450 reductase.
Wilks A; Black SM; Miller WL; Ortiz de Montellano PR
Biochemistry; 1995 Apr; 34(13):4421-7. PubMed ID: 7703255
[TBL] [Abstract][Full Text] [Related]
26. Liver microsomal lipid enhances the activity and redox coupling of colocalized cytochrome P450 reductase-cytochrome P450 3A4 in nanodiscs.
Liu KC; Hughes JMX; Hay S; Scrutton NS
FEBS J; 2017 Jul; 284(14):2302-2319. PubMed ID: 28618157
[TBL] [Abstract][Full Text] [Related]
27. Expression and characterization of full-length human heme oxygenase-1: the presence of intact membrane-binding region leads to increased binding affinity for NADPH cytochrome P450 reductase.
Huber WJ; Backes WL
Biochemistry; 2007 Oct; 46(43):12212-9. PubMed ID: 17915953
[TBL] [Abstract][Full Text] [Related]
28. Steroid biotransformations in biphasic systems with Yarrowia lipolytica expressing human liver cytochrome P450 genes.
Braun A; Geier M; Bühler B; Schmid A; Mauersberger S; Glieder A
Microb Cell Fact; 2012 Aug; 11():106. PubMed ID: 22876969
[TBL] [Abstract][Full Text] [Related]
29. The potential for CYP2D6 inhibition screening using a novel scintillation proximity assay-based approach.
Delaporte E; Slaughter DE; Egan MA; Gatto GJ; Santos A; Shelley J; Price E; Howells L; Dean DC; Rodrigues AD
J Biomol Screen; 2001 Aug; 6(4):225-31. PubMed ID: 11689122
[TBL] [Abstract][Full Text] [Related]
30. Quantitation of human cytochrome P450 2D6 protein with immunoblot and mass spectrometry analysis.
Yu AM; Qu J; Felmlee MA; Cao J; Jiang XL
Drug Metab Dispos; 2009 Jan; 37(1):170-7. PubMed ID: 18832475
[TBL] [Abstract][Full Text] [Related]
31. Identification of danthron as an isoform-specific inhibitor of HEME OXYGENASE-1/cytochrome P450 reductase interaction with anti-tumor activity.
Chou YT; Hsu FF; Hu DY; Chen YC; Hsu YH; Hsu JT; Chau LY
J Biomed Sci; 2018 Jan; 25(1):6. PubMed ID: 29361943
[TBL] [Abstract][Full Text] [Related]
32. Heterologous expression of cytochrome P450 2D6 mutants, electron transfer, and catalysis of bufuralol hydroxylation: the role of aspartate 301 in structural integrity.
Hanna IH; Kim MS; Guengerich FP
Arch Biochem Biophys; 2001 Sep; 393(2):255-61. PubMed ID: 11556812
[TBL] [Abstract][Full Text] [Related]
33. Site-Directed Mutagenesis of Cytochrome P450 2D6 and 2C19 Enzymes: Expression and Spectral Characterization of Naturally Occurring Allelic Variants.
Dong AN; Pan Y; Palanisamy UD; Yiap BC; Ahemad N; Ong CE
Appl Biochem Biotechnol; 2018 Sep; 186(1):132-144. PubMed ID: 29524040
[TBL] [Abstract][Full Text] [Related]
34. Stable Chinese Hamster Ovary Suspension Cell Lines Harboring Recombinant Human Cytochrome P450 Oxidoreductase and Human Cytochrome P450 Monooxygenases as Platform for In Vitro Biotransformation Studies.
Schulz C; Herzog N; Kubick S; Jung F; Küpper JH
Cells; 2023 Aug; 12(17):. PubMed ID: 37681872
[TBL] [Abstract][Full Text] [Related]
35. Cloning and heterologous expression of the NADPH cytochrome P450 oxidoreductase genes from an industrial dicarboxylic acid-producing Candida tropicalis.
He F; Chen YT
Yeast; 2005 Apr; 22(6):481-91. PubMed ID: 15849785
[TBL] [Abstract][Full Text] [Related]
36. Conformational Landscape of Cytochrome P450 Reductase Interactions.
Sellner M; Fischer A; Don CG; Smieško M
Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33498551
[TBL] [Abstract][Full Text] [Related]
37. Expression, purification, biochemical characterization, and comparative function of human cytochrome P450 2D6.1, 2D6.2, 2D6.10, and 2D6.17 allelic isoforms.
Yu A; Kneller BM; Rettie AE; Haining RL
J Pharmacol Exp Ther; 2002 Dec; 303(3):1291-300. PubMed ID: 12438554
[TBL] [Abstract][Full Text] [Related]
38. Mechanism-based inactivation of cytochrome P450 2D6 by 1-[(2-ethyl-4-methyl-1H-imidazol-5-yl)methyl]- 4-[4-(trifluoromethyl)-2-pyridinyl]piperazine: kinetic characterization and evidence for apoprotein adduction.
Hutzler JM; Steenwyk RC; Smith EB; Walker GS; Wienkers LC
Chem Res Toxicol; 2004 Feb; 17(2):174-84. PubMed ID: 14967005
[TBL] [Abstract][Full Text] [Related]
39. Effects of genetic variants of human P450 oxidoreductase on catalysis by CYP2D6 in vitro.
Sandee D; Morrissey K; Agrawal V; Tam HK; Kramer MA; Tracy TS; Giacomini KM; Miller WL
Pharmacogenet Genomics; 2010 Nov; 20(11):677-86. PubMed ID: 20940534
[TBL] [Abstract][Full Text] [Related]
40. Purification, cDNA cloning and functional expression of NADPH-cytochrome P450 reductase from Centaurium erythraea cell cultures.
Schwarz H; Liu B; Peters S; Barillas W; Beerhues L
Plant Biol (Stuttg); 2009 May; 11(3):300-6. PubMed ID: 19470102
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
